SCHEMBL121629

SCHEMBL121629

C1=CNCN=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7159993 0.97
SCHEMBL489475 0.97
SCHEMBL5571161 0.83
SCHEMBL2114538 0.78
SCHEMBL31118099 0.71
SCHEMBL3497375 0.71
SCHEMBL1651586 0.67
SCHEMBL17762727 0.66
SCHEMBL13192015 0.59
SCHEMBL31054450 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9546 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3843845-B1 INHIBITION OF PROTEIN KINASES TO TREAT FRIEDREICH ATAXIA UNIV MASSACHUSETTS (US) 2026-03-11 EP claimed
EP-4266445-B1 SULFUR-BASED BORON TRIFLUORIDE SALT ELECTROLYTE CONTAINING UNSATURATED HETEROCYCLE, PREPARATION METHOD THEREFOR AND USE THEREOF BEIJING WELION NEW ENERGY TECH CO LTD (CN) 2026-01-07 EP claimed
EP-4662211-A1 G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) DEGRADATION COMPOUNDS AND USE THEREOF Nanjing Huanbo Biotechnology Co., Ltd. (CN) 2025-12-17 EP claimed
US-12440494-B2 Compounds useful for inhibiting RAF dimers ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2025-10-14 US claimed
US-12359120-B2 Organometallic compound, organic light-emitting device including organometallic compound, and apparatus including organometallic compound SAMSUNG DISPLAY CO., LTD. (KR) 2025-07-15 US claimed
CN-120157666-A Dihydropyrimidine compound, preparation method and application thereof, dihydropyrimidine derivative and application thereof, pharmaceutical composition and application thereof 中国医学科学院医药生物技术研究所 2025-06-17 CN claimed
US-20250188078-A1 SMALL MOLECULE INHIBITORS OF THE CRL4 UBIQUITIN LIGASE CORNELL UNIVERSITY (US) 2025-06-12 US claimed
US-12281308-B2 Inhibition of protein kinases to treat Friedreich ataxia UNIVERSITY OF MASSACHUSETTS (US) 2025-04-22 US claimed
CN-119708003-A Organic small molecule semiconductor difunctional material, preparation method and application thereof 西安近代化学研究所 2025-03-28 CN claimed
EP-4522613-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS Biotheryx, Inc. (US) 2025-03-19 EP claimed
EP-0232716-A2 Polyphenylene ethers of improved stability GENERAL ELECTRIC COMPANY (US) 1987-08-19 EP claimed
US-4687590-A Oil-in-alcohol microemulsion containing oil-soluble corrosion inhibitor in antifreeze FIRST BRANDS CORPORATION (US) 1987-08-18 US claimed
EP-0195374-A2 N-substituted 3,4-dihydropyrimidine derivatives, process for the production thereof and composition containing same for treating disorders of cardiovascular system SUNTORY LIMITED (JP) 1986-09-24 EP claimed
EP-0189883-A1 5-Oxo-pyrido[4,3-d]pyrimidine derivatives, process for their preparation and medicaments containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1986-08-06 EP claimed
EP-0173377-A2 Pyrimidone compounds, their preparation and pharmaceutical compositions containing them YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1986-03-05 EP claimed
EP-0148128-A2 Optically active penem compounds CIBA-GEIGY AG (CH) 1985-07-10 EP claimed
EP-0103796-A2 Dihydropyrimidines, process for their preparation and their use in medicaments BAYER AG (DE) 1984-03-28 EP claimed
US-4272606-A HYDRAZIDE, THIOAMIDE FUJI PHOTO FILM CO., LTD. (JP) 1981-06-09 US claimed
US-4094811-A REDUCING SILVER SALTS IN THE PRESENCE OF A HETEROCYCLIC 5- OR 6-MEMBERED NITROGEN COMPOUND AGFA-GEVAERT AKTIENGESELLSCHAFT (DT) 1978-06-13 US claimed
US-4034093-A INHIBITION OF XANTHINEOXIDASE BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DT) 1977-07-05 US claimed